biotechnology entrepreneurship || contributors
Post on 25-Dec-2016
216 Views
Preview:
TRANSCRIPT
Contributors
Chris Allen, MS Senior Manager Facilities and Engineering, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Jack M. Anthony Founder and Principal, BioMentorz, Inc., Healdsburg, California
Norman W. Baylor, PhD President & CEO, Biologics Consulting Group, Inc., Alexandria, Virginia
John F. Beeler, PhD Director, Theranostics and Business Development bioMerieux, Cambridge, Massachusetts
Dave Boclair Manager Manufacturing Downstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Arthur A. Boni, PhD John R. Thorne Distinguished Career Professor of Entrepreneurship, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania
Craig C. Bradley, JD Partner, Edwards Wildman Palmer LLP, Chicago, Illinois
G. Steven Burrill CEO, Burrill & Company, San Francisco, California
Lowell W. Busenitz, PhD, MBA Academic Director, Price College Center for Entrepreneurship, University of Oklahoma, Norman, Oklahoma
Robert J. Calcaterra, DSC President, St. Louis Arch Angels, St. Louis, Missouri
John Conner, MS Vice President Manufacturing Science and Technology, Cytovance Biologics, Inc., Oklahoma City, Oklahoma
Gerry J. Elman, MS, JD Elman Technology Law, P.C., Swarthmore, Pennsylvania
Steven M. Ferguson, CLP Deputy Director, Licensing & Entrepreneurship, Office of Technology Transfer, National Institutes of Health, Rockville, Maryland
Toby Freedman, PhD President, Synapsis Search Recruiting, Portolavalley, California
Susan Garfield, DrPH Senior Vice President, GfK Custom Research LLC, Wayland, Massachusetts
James C. Greenwood President & CEO, Biotechnology Industry Organization (BIO), Washington, D.C.
Neal Gutterson, PhD President & CEO, Mendel Biotechnology, Hayward, California
Phil Haworth, PhD, JD Principal, Biomentorz, Inc. Redwood City, California
Uma S. Kaundinya, PhD, CLP President & CEO, Aavishkar Innovations Inc., Bedford, Massachusetts
Donald R. Kirsch, PhD Chief Scientific Officer, Cambria Pharmaceuticals, Cambridge, Massachusetts
Joan E. Kureczka, MSEM Founder and Principal, Kureczka/Martin Associates and The Vivant Group, San Francisco, California
Lynn Johnson Langer, PhD, MBA Director, Enterprise and Regulatory Science Programs Center for Biotechnology Education, Johns Hopkins University, Rockville, Maryland
Maria Lopez Vice President Quality Systems, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Lara V. Marks, D.Phil. (Oxon) Senior Research Fellow, Department of Social Science, Health and Medicine, King’s College, London, England
Bill Minshall, MS Senior Vice President Regulatory Affairs, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Jay Peterson Manager Manufacturing Upstream Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Rabi Prusti, PhD Executive Director Quality Control, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Craig Shimasaki, PhD, MBA President & CEO, Moleculera Labs and BioSource Consulting Group, Oklahoma City, Oklahoma
Henri A. Termeer Former Chairman, CEO and President of Genzyme Corporation, Cambridge, Massachusetts
Gergana Todorova, PhD Assistant Professor, School of Business Administration, University of Miami, Coral Gables, Florida
Tom D. Walker CEO & President, TechColumbus, Inc., Columbus, Ohio
xix
Contributorsxx
Robert E. Wanerman, JD, MPH Epstein Becker Green, P.C., Washington, D.C.
Laurie R. Weingart, PhD Carnegie Bosch Professor of Organizational Behavior and Theory, Tepper School of Business at Carnegie Mellon University, Pittsburgh, Pennsylvania
Gladys B. White, PhD Adjunct Professor of Liberal Studies, Georgetown University, Washington, D.C.
Don Wuchterl Senior Vice President Operations, Cytovance Biologics Inc., Oklahoma City, Oklahoma
Jay Z. Zhang, MS, JD Shuwen Biotech Co. Ltd., Deqing, Zhejiang Province, China and Momentous IP Ventures LLC, Salt Lake City, Utah
top related